AOD 9604 10mg is typically used in structured fat-loss protocols where the primary goals are body-fat reduction, improved fat mobilisation, and better adherence to longer-term weight-loss plans. It is generally positioned as a body-fat-focused peptide rather than a stimulant-style product, which makes it relevant both to lifestyle fat-loss use and to more physique-focused protocols where reducing body fat is the main objective.

This product is most relevant where fat loss is the priority, particularly in protocols aimed at improving body composition over time through consistent daily use. It may appeal both to lifestyle users seeking additional support in a calorie-controlled phase and to more performance-focused users looking for a cleaner fat-loss adjunct without a harsh stimulant profile.

How It Works

AOD 9604 is a modified fragment of human growth hormone designed to target the lipolytic, fat-metabolism-related activity associated with the parent hormone, without reproducing the broader growth-promoting effects of full HGH.

In practical use, it is typically selected where the goal is to support fat loss, improve body-fat utilisation, and complement broader diet and activity measures. It is usually run consistently rather than used as an acute “feel it immediately” compound.

Reconstitution Guideline

Total vial content: 10mg

Suggested reconstitution: 2mL bacteriostatic water

Resulting concentration:

• 5mg/mL

Dosage reference:

• 0.04mL = 200mcg
• 0.06mL = 300mcg
• 0.08mL = 400mcg
• 0.10mL = 500mcg
• 0.20mL = 1mg

This dilution keeps standard fat-loss dosing in a clean, low-volume range.

Dosage Protocol

AOD 9604 is typically used as a once-daily fat-loss support peptide.

Standard Dosing

• Dose: 300–500mcg once daily
• Timing: Commonly used in the morning, often before food
• Frequency: Daily
• Run length: Commonly 8–12 weeks

Practical Dose Examples

At 2mL reconstitution:

• 300mcg = 0.06mL
• 400mcg = 0.08mL
• 500mcg = 0.10mL

Higher-End Reference Point

Some protocols reference 1mg daily as a higher-end structure, though the more common practical range remains 300–500mcg daily.

Administration

Subcutaneous administration is the standard practical format in peptide-style protocols, usually as a once-daily injection.

Expectations

AOD 9604 is generally used for cumulative body-fat support rather than for an acute noticeable effect. It is usually positioned as a consistency-driven compound, where results are expected to develop over time alongside dietary control and broader fat-loss structure.

Expected Outcomes

• Body-fat reduction support
• Structured fat-loss protocol support
• Improved body composition over time
• Fat-loss support without a stimulant-focused profile
• Longer-term calorie-controlled phases where consistent daily support is preferred

Stacking / Pairing

AOD 9604 is commonly positioned alongside:

• Broader fat-loss protocols where body-fat reduction is the primary goal
• Appetite-control products where intake management and fat loss are being addressed together
• Physique-focused protocols where leaner body composition is the main objective

It is best treated as a body-fat support peptide rather than a broad recovery or wellness compound.

Cautions

• Reconstituted product should be refrigerated after mixing.
• Sterile technique should be used during reconstitution and handling.
• A conservative starting dose is generally preferred.
• Protocol structure should be matched to actual fat-loss goals rather than escalated unnecessarily.
• Not suitable for use where contraindicated.